000 | 01595 a2200445 4500 | ||
---|---|---|---|
005 | 20250510211258.0 | ||
264 | 0 | _c19790829 | |
008 | 197908s 0 0 eng d | ||
022 | _a0090-4295 | ||
024 | 7 |
_a10.1016/0090-4295(79)90401-1 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFinkbeiner, A E | |
245 | 0 | 0 |
_aUropharmacology: XI. Adrenergic-blocking agents and drugs affecting catecholamine binding and release. _h[electronic resource] |
260 |
_bUrology _cJun 1979 |
||
300 |
_a693-700 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAdrenergic Agents _xpharmacology |
650 | 0 | 4 |
_aAdrenergic alpha-Antagonists _xpharmacology |
650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBretylium Compounds _xpharmacology |
650 | 0 | 4 |
_aDihydroergotamine _xpharmacology |
650 | 0 | 4 |
_aGuanethidine _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMethyldopa _xpharmacology |
650 | 0 | 4 |
_aMuscle, Smooth _xdrug effects |
650 | 0 | 4 |
_aPhenoxybenzamine _xpharmacology |
650 | 0 | 4 |
_aPhentolamine _xpharmacology |
650 | 0 | 4 |
_aPropranolol _xpharmacology |
650 | 0 | 4 |
_aUrethra _xdrug effects |
650 | 0 | 4 |
_aUrinary Bladder _xdrug effects |
650 | 0 | 4 |
_aUrinary Bladder, Neurogenic _xdrug therapy |
650 | 0 | 4 |
_aUrinary Tract _xdrug effects |
650 | 0 | 4 |
_aUrination Disorders _xdrug therapy |
700 | 1 | _aWelch, L T | |
700 | 1 | _aBissada, N K | |
773 | 0 |
_tUrology _gvol. 13 _gno. 6 _gp. 693-700 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/0090-4295(79)90401-1 _zAvailable from publisher's website |
999 |
_c86120 _d86120 |